Thyrocare Technologies Limited
Symboli: THYROCARE.BO
BSE
603.8
INRMarkkinahinta tänään
50.3318
P/E-suhde
0.9063
PEG-suhde
31.97B
MRK Cap
- 0.00%
DIV Tuotto
Thyrocare Technologies Limited (THYROCARE-BO) Tilinpäätöstiedotteet
Tase
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1400.7 | 1388.4 | 1176.9 | |||||||||
balance-sheet.row.short-term-investments | 0 | 1223 | 1252.1 | 1044.9 | |||||||||
balance-sheet.row.net-receivables | 0 | 856.7 | 944.8 | 513.5 | |||||||||
balance-sheet.row.inventory | 0 | 276.7 | 245.3 | 233.6 | |||||||||
balance-sheet.row.other-current-assets | 0 | 53.2 | 112.8 | 28.4 | |||||||||
balance-sheet.row.total-current-assets | 0 | 2729.4 | 2700.2 | 2404.4 | |||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 1944.3 | 1867.9 | 1600.9 | |||||||||
balance-sheet.row.goodwill | 0 | 1002.8 | 1002.8 | 1002.8 | |||||||||
balance-sheet.row.intangible-assets | 0 | 7.9 | 8.3 | 9.7 | |||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1010.7 | 1011.1 | 1012.5 | |||||||||
balance-sheet.row.long-term-investments | 0 | 223.1 | 243.8 | 270.7 | |||||||||
balance-sheet.row.tax-assets | 0 | 122.7 | 64.9 | 56.3 | |||||||||
balance-sheet.row.other-non-current-assets | 0 | 297 | 188.7 | 113.2 | |||||||||
balance-sheet.row.total-non-current-assets | 0 | 3597.8 | 3376.4 | 3053.6 | |||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-assets | 0 | 6327.2 | 6076.6 | 5458 | |||||||||
balance-sheet.row.account-payables | 0 | 239.9 | 165.3 | 250.1 | |||||||||
balance-sheet.row.short-term-debt | 0 | 71.9 | 50 | 30.4 | |||||||||
balance-sheet.row.tax-payables | 0 | 18.3 | 18.3 | 18.6 | |||||||||
balance-sheet.row.long-term-debt-total | 0 | 161.2 | 157 | 54.5 | |||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 91.9 | |||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||
balance-sheet.row.other-current-liab | 0 | 398.4 | 336.5 | 312.5 | |||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 204 | 165.7 | 234.2 | |||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.capital-lease-obligations | 0 | 233.1 | 207 | 84.9 | |||||||||
balance-sheet.row.total-liab | 0 | 975 | 810.9 | 1185.2 | |||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.common-stock | 0 | 529.3 | 529 | 528.7 | |||||||||
balance-sheet.row.retained-earnings | 0 | 3434.2 | 3568.8 | 2599.2 | |||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 1255.9 | 1244.1 | 1225.8 | |||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 123.6 | -76.2 | -80.9 | |||||||||
balance-sheet.row.total-stockholders-equity | 0 | 5343 | 5265.7 | 4272.8 | |||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 6327.2 | 6076.6 | 5458 | |||||||||
balance-sheet.row.minority-interest | 0 | 9.2 | 0 | 0 | |||||||||
balance-sheet.row.total-equity | 0 | 5352.2 | 5265.7 | 4272.8 | |||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||
Total Investments | 0 | 221 | 209.2 | 211 | |||||||||
balance-sheet.row.total-debt | 0 | 233.1 | 207 | 84.9 | |||||||||
balance-sheet.row.net-debt | 0 | 55.4 | 70.7 | -47.1 |
Kassavirtalaskelma
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 874.1 | 2279 | 1525.4 | |||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 387.1 | 338.7 | 302.8 | |||||||||||
cash-flows.row.deferred-income-tax | 0 | -247.4 | -731.2 | -522.2 | |||||||||||
cash-flows.row.stock-based-compensation | 0 | 211.7 | 23.2 | 16.8 | |||||||||||
cash-flows.row.change-in-working-capital | 0 | 57.9 | -792.2 | -176.5 | |||||||||||
cash-flows.row.account-receivables | 0 | -14.3 | -587.2 | -288.1 | |||||||||||
cash-flows.row.inventory | 0 | -31.4 | -11.7 | -27.4 | |||||||||||
cash-flows.row.account-payables | 0 | 74.2 | -84.8 | 31.5 | |||||||||||
cash-flows.row.other-working-capital | 0 | 29.4 | -108.5 | 107.5 | |||||||||||
cash-flows.row.other-non-cash-items | 0 | 9.7 | 16.6 | 1 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -436.5 | -378.3 | -266.9 | |||||||||||
cash-flows.row.acquisitions-net | 0 | 30.2 | 42.5 | 42.5 | |||||||||||
cash-flows.row.purchases-of-investments | 0 | -1919.9 | -1730 | -1361.1 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 1932.5 | 1593.5 | 1042.1 | |||||||||||
cash-flows.row.other-investing-activites | 0 | 3.8 | 236.6 | 56.8 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -389.9 | -235.7 | -486.6 | |||||||||||
cash-flows.row.debt-repayment | 0 | -55.3 | -53.8 | -25 | |||||||||||
cash-flows.row.common-stock-issued | 0 | 0.3 | 0.3 | 0.3 | |||||||||||
cash-flows.row.common-stock-repurchased | 0 | -55.3 | -53.8 | -62.6 | |||||||||||
cash-flows.row.dividends-paid | 0 | -793.5 | -793.1 | -528.4 | |||||||||||
cash-flows.row.other-financing-activites | 0 | 42 | 6.3 | -0.1 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -861.8 | -894.1 | -615.8 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | -2.5 | |||||||||||
cash-flows.row.net-change-in-cash | 0 | 41.4 | 4.3 | 44.9 | |||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 177.7 | 136.3 | 132 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 136.3 | 132 | 87.1 | |||||||||||
cash-flows.row.operating-cash-flow | 0 | 1293.1 | 1134.1 | 1147.3 | |||||||||||
cash-flows.row.capital-expenditure | 0 | -436.5 | -378.3 | -266.9 | |||||||||||
cash-flows.row.free-cash-flow | 0 | 856.6 | 755.8 | 880.4 |
Tuloslaskelmarivi
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 5266.7 | 5888.6 | 4946.2 | |||||||||
income-statement-row.row.cost-of-revenue | 0 | 1632.3 | 1696.9 | 1639 | |||||||||
income-statement-row.row.gross-profit | 0 | 3634.4 | 4191.7 | 3307.2 | |||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.other-expenses | 0 | 4.4 | 18 | 21.2 | |||||||||
income-statement-row.row.operating-expenses | 0 | 2788.2 | 2173.1 | 1895.9 | |||||||||
income-statement-row.row.cost-and-expenses | 0 | 4420.5 | 3870 | 3534.9 | |||||||||
income-statement-row.row.interest-income | 0 | 13.8 | 7.1 | 7.9 | |||||||||
income-statement-row.row.interest-expense | 0 | 23.5 | 23.7 | 8.7 | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -0.4 | 227.9 | 61.8 | |||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||
income-statement-row.row.other-operating-expenses | 0 | 4.4 | 18 | 21.2 | |||||||||
income-statement-row.row.total-operating-expenses | 0 | -0.4 | 227.9 | 61.8 | |||||||||
income-statement-row.row.interest-expense | 0 | 23.5 | 23.7 | 8.7 | |||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 387.1 | 338.7 | 302.8 | |||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||
income-statement-row.row.operating-income | 0 | 865.5 | 2044.2 | 1455.9 | |||||||||
income-statement-row.row.income-before-tax | 0 | 885.9 | 2277.2 | 1524.7 | |||||||||
income-statement-row.row.income-tax-expense | 0 | 242.3 | 515.8 | 393.2 | |||||||||
income-statement-row.row.net-income | 0 | 643.6 | 1761.4 | 1131.5 |
Usein kysytty kysymys
Mikä on Thyrocare Technologies Limited (THYROCARE.BO) taseen loppusumma?
Thyrocare Technologies Limited (THYROCARE.BO) kokonaisvarat ovat 6327200000.000.
Mikä on yrityksen vuotuinen liikevaihto?
Vuotuinen liikevaihto on N/A.
Mikä on yrityksen voittomarginaali?
Yrityksen voittomarginaali on 0.708.
Mikä on yrityksen vapaa kassavirta?
Vapaa kassavirta on 16.845.
Mikä on yrityksen nettovoittomarginaali?
Nettovoittomarginaali on 0.118.
Mikä on yrityksen kokonaistulot?
Kokonaisliikevaihto on 0.151.
Mikä on Thyrocare Technologies Limited (THYROCARE.BO) nettovoitto (nettotulos)?
Nettovoitto (nettotulos) on 643600000.000.
Mikä on yrityksen kokonaisvelka?
Kokonaisvelka on 233100000.000.
Mikä on yrityksen toimintakulujen määrä?
Toimintakulut ovat 2788200000.000.
Mikä on yrityksen kassan määrä?
Yrityksen kassavarat ovat 0.000.